Humoral immunoresponse to varicella-zoster virus pernasally coadministered with Escherichia coli enterotoxin in mice

Takao Tsuji, Kimiyasu Shiraki, Hiroshi Sato, Jiang Yue-Mea, Yasuko Honma, Tetsushi Yoshikawa, Yoshizo Asano

研究成果: Article

8 引用 (Scopus)

抄録

It is evaluated whether Escherichia coli enterotoxin is useful for induction of immunity to varicella-zoster virus (VZV) as a mucosal adjuvant in mice. When a commercially available live varicella vaccine (Oka strain) and toxin were administered simultaneously via a nasal route three times at 2 or 6 month intervals, an antibody neutralizing VZV was detected in half or all of the mice vaccinated, respectively. The antibody specific to the vaccine strain of VZV reacted to five proteins, molecular weights of which were 110 K, 100 K, 62 K, 54 K and 46 K. These proteins were composed of glycosylated products of all kinds of glycoproteins. These results suggest that although a nasal administration of the vaccine without the adjuvant has little immunogenicity in mice, the simultaneous administration of the live vaccine and the toxin over a long period induces a specific humoral immunity to VZV. Copyright (C) 2000 Elsevier Science Ltd.

元の言語English
ページ(範囲)2049-2054
ページ数6
ジャーナルVaccine
18
発行部数19
DOI
出版物ステータスPublished - 03-04-2000

Fingerprint

Human herpesvirus 3
Human Herpesvirus 3
Enterotoxins
enterotoxins
Escherichia coli
Vaccines
mice
toxins
Chickenpox Vaccine
vaccines
intranasal administration
Intranasal Administration
vaccine adjuvants
live vaccines
Humoral Immunity
Neutralizing Antibodies
neutralizing antibodies
Nose
humoral immunity
adjuvants

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

これを引用

Tsuji, Takao ; Shiraki, Kimiyasu ; Sato, Hiroshi ; Yue-Mea, Jiang ; Honma, Yasuko ; Yoshikawa, Tetsushi ; Asano, Yoshizo. / Humoral immunoresponse to varicella-zoster virus pernasally coadministered with Escherichia coli enterotoxin in mice. :: Vaccine. 2000 ; 巻 18, 番号 19. pp. 2049-2054.
@article{bdaf8f384bfc4e468d7ac7df373c7220,
title = "Humoral immunoresponse to varicella-zoster virus pernasally coadministered with Escherichia coli enterotoxin in mice",
abstract = "It is evaluated whether Escherichia coli enterotoxin is useful for induction of immunity to varicella-zoster virus (VZV) as a mucosal adjuvant in mice. When a commercially available live varicella vaccine (Oka strain) and toxin were administered simultaneously via a nasal route three times at 2 or 6 month intervals, an antibody neutralizing VZV was detected in half or all of the mice vaccinated, respectively. The antibody specific to the vaccine strain of VZV reacted to five proteins, molecular weights of which were 110 K, 100 K, 62 K, 54 K and 46 K. These proteins were composed of glycosylated products of all kinds of glycoproteins. These results suggest that although a nasal administration of the vaccine without the adjuvant has little immunogenicity in mice, the simultaneous administration of the live vaccine and the toxin over a long period induces a specific humoral immunity to VZV. Copyright (C) 2000 Elsevier Science Ltd.",
author = "Takao Tsuji and Kimiyasu Shiraki and Hiroshi Sato and Jiang Yue-Mea and Yasuko Honma and Tetsushi Yoshikawa and Yoshizo Asano",
year = "2000",
month = "4",
day = "3",
doi = "10.1016/S0264-410X(99)00487-9",
language = "English",
volume = "18",
pages = "2049--2054",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "19",

}

Humoral immunoresponse to varicella-zoster virus pernasally coadministered with Escherichia coli enterotoxin in mice. / Tsuji, Takao; Shiraki, Kimiyasu; Sato, Hiroshi; Yue-Mea, Jiang; Honma, Yasuko; Yoshikawa, Tetsushi; Asano, Yoshizo.

:: Vaccine, 巻 18, 番号 19, 03.04.2000, p. 2049-2054.

研究成果: Article

TY - JOUR

T1 - Humoral immunoresponse to varicella-zoster virus pernasally coadministered with Escherichia coli enterotoxin in mice

AU - Tsuji, Takao

AU - Shiraki, Kimiyasu

AU - Sato, Hiroshi

AU - Yue-Mea, Jiang

AU - Honma, Yasuko

AU - Yoshikawa, Tetsushi

AU - Asano, Yoshizo

PY - 2000/4/3

Y1 - 2000/4/3

N2 - It is evaluated whether Escherichia coli enterotoxin is useful for induction of immunity to varicella-zoster virus (VZV) as a mucosal adjuvant in mice. When a commercially available live varicella vaccine (Oka strain) and toxin were administered simultaneously via a nasal route three times at 2 or 6 month intervals, an antibody neutralizing VZV was detected in half or all of the mice vaccinated, respectively. The antibody specific to the vaccine strain of VZV reacted to five proteins, molecular weights of which were 110 K, 100 K, 62 K, 54 K and 46 K. These proteins were composed of glycosylated products of all kinds of glycoproteins. These results suggest that although a nasal administration of the vaccine without the adjuvant has little immunogenicity in mice, the simultaneous administration of the live vaccine and the toxin over a long period induces a specific humoral immunity to VZV. Copyright (C) 2000 Elsevier Science Ltd.

AB - It is evaluated whether Escherichia coli enterotoxin is useful for induction of immunity to varicella-zoster virus (VZV) as a mucosal adjuvant in mice. When a commercially available live varicella vaccine (Oka strain) and toxin were administered simultaneously via a nasal route three times at 2 or 6 month intervals, an antibody neutralizing VZV was detected in half or all of the mice vaccinated, respectively. The antibody specific to the vaccine strain of VZV reacted to five proteins, molecular weights of which were 110 K, 100 K, 62 K, 54 K and 46 K. These proteins were composed of glycosylated products of all kinds of glycoproteins. These results suggest that although a nasal administration of the vaccine without the adjuvant has little immunogenicity in mice, the simultaneous administration of the live vaccine and the toxin over a long period induces a specific humoral immunity to VZV. Copyright (C) 2000 Elsevier Science Ltd.

UR - http://www.scopus.com/inward/record.url?scp=0034004292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034004292&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(99)00487-9

DO - 10.1016/S0264-410X(99)00487-9

M3 - Article

C2 - 10706968

AN - SCOPUS:0034004292

VL - 18

SP - 2049

EP - 2054

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 19

ER -